ZYNERBA PHARMACEUTICALS, INC. Additional Paid in Capital
ZYNERBA PHARMACEUTICALS, INC. had Additional Paid in Capital of $324.37 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2023-08-14
- 2023-06-30: Additional Paid in Capital $324.37M.
- 2023-03-31: Additional Paid in Capital $323.54M.
- 2022-12-31: Additional Paid in Capital $320.70M.
- 2022-09-30: Additional Paid in Capital $319.21M.
| Period end | Additional Paid in Capital |
|---|---|
| 2023-06-30 | $324.37M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $323.54M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $320.70M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $319.21M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $315.02M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $313.10M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $310.35M 10-K · filed 2023-03-28 |
| 2021-09-30 | $309.31M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $307.74M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $305.81M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $262.29M 10-K · filed 2022-03-01 |
| 2020-09-30 | $259.16M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $257.90M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $229.31M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $226.41M 10-K · filed 2021-03-10 |
| 2019-09-30 | $225.11M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $223.73M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $195.05M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $175.48M 10-K · filed 2020-03-10 |
| 2018-09-30 | $173.88M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $142.36M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $140.60M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $138.92M 10-K · filed 2019-03-11 |
| 2017-09-30 | $134.49M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $132.77M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $130.98M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $75.55M 10-K · filed 2018-03-12 |
| 2016-09-30 | $69.95M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $63.85M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $63.04M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $62.28M 10-K · filed 2017-03-27 |
| 2015-09-30 | $61.51M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.98M 10-Q · filed 2015-08-27 |
| 2014-12-31 | $1.98M 10-K · filed 2016-03-14 |